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Abstract
Anemia caused by trypanosome infection is poorly understood. Autoimmunity during Trypa-
nosoma brucei infection was proposed to have a role during anemia, but the mechanisms
involved during this pathology have not been elucidated. In mouse models and human
patients infected with malaria parasites, atypical B-cells promote anemia through the secre-
tion of autoimmune anti-phosphatidylserine (anti-PS) antibodies that bind to uninfected
erythrocytes and facilitate their clearance. Using mouse models of two trypanosome infec-
tions, Trypanosoma brucei and Trypanosoma cruzi, we assessed levels of autoantibodies
and anemia. Our results indicate that acute T. brucei infection, but not T. cruzi, leads to
early increased levels of plasma autoantibodies against different auto antigens tested (PS,
DNA and erythrocyte lysate) and expansion of atypical B cells (ABCs) that secrete these
autoantibodies. In vitro studies confirmed that a lysate of T. brucei, but not T. cruzi, could
directly promote the expansion of these ABCs. PS exposure on erythrocyte plasma mem-
brane seems to be an important contributor to anemia by delaying erythrocyte recovery
since treatment with an agent that prevents binding to it (Annexin V) ameliorated anemia in
T. brucei-infected mice. Analysis of the plasma of patients with human African trypanosomi-
asis (HAT) revealed high levels of anti-PS antibodies that correlated with anemia. Altogether
these results suggest a relation between autoimmunity against PS and anemia in both mice
and patients infected with T. brucei.
Author summary
African trypanosomes are relevant pathogens and a cause of great morbidity and eco-
nomic burden in endemic countries. Anemia during infection by African Trypanosomes
is one of the most common pathologies associated with the disease, but the mechanisms
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leading to it are poorly understood. Here, we report evidence of autoimmunity, particu-
larly autoantibodies against the lipid phosphatidylserine that are secreted by autoim-
mune/atypical B-cells, in Trypanosoma brucei infected mice and that are also found in
Human African Trypanosomiasis patients and correlate with levels of anemia. These find-
ings point to a relation between autoimmunity and anemia during infection with African
Trypanosomes, possibly through the secretion of autoantibodies against
phosphatidylserine.
Introduction
Anemia is a very common, but poorly understood, complication in many infectious diseases,
including protozoan parasitic infections, such as trypanosomiasis and malaria. Trypanosomes
are eukaryotic parasites that cause a range of diseases and are characterized by their geographi-
cal endemicity. The most relevant human trypanosome pathogens are Trypanosoma brucei
and Trypanosoma cruzi, that cause sleeping sickness in Africa, and Chagas disease in the
Americas, respectively [1,2]. Both infections, but particularly Trypanosoma brucei, lead to
some degree of anemia [3,4].
Autoimmunity is defined as a misguided response against the host own tissues, cells and
molecules leading to pathology. Autoimmune anemia has been a well-documented complica-
tion during different infections but has been complex to understand due to its multi-factorial
etiology [5]. During malaria, autoimmune antibodies targeting the membrane lipid phosphati-
dylserine (PS) exposed in the membrane of uninfected erythrocytes promote their lysis and
premature clearance in both mice and humans, aggravating anemia [6–11]. These anti-PS
autoantibodies are secreted primarily by autoimmune B-cells (called atypical B-cells or Age-
Associated B-cells, ABCs), that are characterized by the expression of the transcription factor
T-bet and the integrin CD11c, and associated with anemia during malaria [12]. A role for
autoimmunity in promoting anemia during trypanosomiasis has been suggested [3] but
remains poorly understood.
Using an acute mouse model of African trypanosomiasis, we show here that, similarly to
malaria, there are early high levels of autoimmune antibodies in an acute Trypanosoma brucei
brucei (T. b. brucei) mouse infection. This was not observed in an acute mouse model of Cha-
gas disease. Our results also show an increase in the expansion of ABCs during acute T. b. bru-
cei infection in mice, which are able to secrete specific anti-PS autoantibodies. We observed
that T. b. brucei lysates could directly promote the differentiation of ABCs in synergy with
other inflammatory signals, as described in other infections and autoimmune mice models. PS
exposed on the surface of erythrocytes seems to be a significant target during autoimmune
anemia, since injection of the specific PS-binding protein annexin V enhanced RBC recovery
in T. b. brucei-infected mice. Lastly, levels of IgM and IgG anti-PS antibodies are significantly
elevated in the plasma of Human African Trypanosomiasis (HAT) patients and correlate with




The patient samples included in this manuscript are from a previous study [13] approved by
the Grampian Research Ethics Committee (Aberdeen, UK) and the Ministry of Health
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(Uganda). This study was conducted according to the principles expressed in the Declaration
of Helsinki. All patients recruited received written and verbal information explaining the pur-
pose of this study and gave informed consent. The ethical committees in Uganda (Ministry of
Health), Malawi (College of Medicine) and the UK (Grampian Joint Ethics Committee)
approved all protocols. Ethical consent forms were designed in English and also translated
into local languages. Consent was given as a signature or a thumb print after verbal
explanation.
Mice, parasites, and infections
This study was carried out in strict accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was
approved by the Institutional Animal Care and Use Committee of New York University School
of Medicine, which are fully accredited by the Association For Assessment and Accreditation
Of Laboratory Animal Care International (AAALAC). Female BALB/c and Swiss-Webster
mice 6 to 8 weeks old were purchased from the National Institutes of Health (Bethesda, MD)
and The Jackson Laboratory (Bar Harbor, ME). All protocols used have been validated and are
routinely used by the NYU Anti-Infectives Screening Core.
For T. brucei infection, 6 Swiss-Webster mice were injected i.p. with 104 T.b. brucei AnTaR
1 expressing Renilla luciferase [14] bloodstream forms obtained from culture in HMI-9
medium, resuspended in PBS, final volume 250 μl. The transgenic luciferase-expressing para-
site was generously provided by Nick Van Reet, PhD, of the Institute of Tropical Medicine in
Antwerp, Belgium [15]. Mice were kept until day 13 post-infection as indicated in our IACUC
protocol.
For T. cruzi infection, 6 BALB/c mice were injected i.p. with 106 trypomastigotes of T. cruzi
Brazil strain expressing firefly luciferase [16] obtained from culture in NIH-3T3 cells. For puri-
fication, infected NIH-3T3 culture media was centrifuged for 7 min at 2500 rpm and trypo-
mastigotes were allowed to swim out of the pellet for 3 h at 37˚C. Supernatant containing free
swimming trypanosomes was removed, centrifuged again and resuspended in PBS for injec-
tion at a final volume 250 μl per mouse. The luciferase-expressing parasite was generously pro-
vided by Barbara Burleigh, PhD, of Harvard University T. H. Chan School of Public Health,
Boston, US.
At days 8 and 12 after infection, the mice were anesthetized by inhalation of isofluorane
(controlled flow of 1.5% isoflurane in air was administered through a nose cone via a gas anes-
thesia system). Mice were injected with 200 μl of 150 mg/kg of D-Luciferin Potassium-salt
(Goldbio) dissolved in PBS for T. cruzi infections and with 100 μl of a coelenterazine native
solution (10 mg/mouse) for T. brucei and imaged 5 to 10 min after with an IVIS Lumina II
imager (Xenogen, Alameda, CA). Data acquisition and analysis were performed with the soft-
ware LivingImage (Xenogen). The luciferin signal is proportional to the parasite load.
For the in vivo model of anemia, mice were i.p. infected with T. b. brucei followed by i.v.
injection of annexin V (200 μg/mouse, Sigma, St. Louis, MO) or vehicle (PBS) on days 3 and 7
post infection as established in a previous malarial anemia study [10]. Anemia was assessed by
tail puncture blood collection and erythrocytes were counted in a hemocytometer. This experi-
ment was performed in two independent infections, each with 6 mice total (3 mice per group).
Values from 6 mice total were averaged for each time point.
For Plasmodium yoelii infections, female Swiss Webster mice were injected i.p. with 106
infected RBCs per mouse of the nonlethal strain P. yoelii 17XNL resuspended in PBS, final vol-
ume 250 μl. To evaluate parasitemia, thin blood smears were made by bleeding mice from a
nick in the tail. Smears were stained with KaryoMAX Giemsa (Life Technologies, Norwalk,
PLOS NEGLECTED TROPICAL DISEASES T. brucei-induced anemia is associated with autoimmunity
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0009814 September 29, 2021 3 / 18
CT), and a minimum of 500 RBCs per smear were counted. To evaluate anemia, RBC numbers
were counted in Neubauer Chamber in an inverted light- microscope. P. yoelii 17XNL-infected
RBCs were harvested by cardiac puncture of infected, anesthetized mice before the peak of
parasitemia. RBCs were washed twice with PBS and separated from white blood cells by centri-
fugation at 2000 × g for 3 min. P. yoelii-infected RBCs were isolated through LD magnetic col-
umns (Miltenyi) and infected erythrocytes were lysed by freeze–thaw 10 times with liquid
nitrogen and kept sterile.
Flow cytometry
All flow cytometry was performed on a FACSCalibur (Becton Dickinson, Franklin Lakes, NJ)
and analyzed with FlowJo software (Tree Star, Ashland, OR). All samples were incubated with
FcR-blocking agent (BD Bioscience, clone 2.4G2) prior to staining with fluorescent antibodies.
To characterize mouse CD11c+T-bet+B cells the following antibodies (BioLegend (San Diego,
CA) were used at 1 μg/ml: anti-CD19-FITC(6D5), anti-T-bet-PE (4B10), anti-B220-PRCP
(RA3-6B2); and anti-CD11c-APC (N418). All antibodies were matched with their correct fluo-
rescent-conjugated isotype control. Intracellular T-bet staining was performed using the True-
Nuclear Transcription Factor Buffer Set (Biolegend) and following manufacturer’s instruc-
tions. In brief, for intracellular staining, cells were fixed after surface staining at 4˚C with
True-NuclearTranscription Factor 1X Fix reagent (Biolegend) for 40 minutes. Then cells were
permeabilized with a Transcription Factor Staining Kit 1X Perm reagent by washing 3 times,
followed by staining with anti-T-bet-PE (4B10) for 30 minutes, washed 3 more times with 1X
Perm reagent and then resuspended in FACS buffer (PBS 1X 0.5% BSA 2mM EDTA) for flow
cytometry analysis. To assess ABCs, we used standard ABC gating strategies [17–19] (S1 Fig).
To assess PS exposure on RBCs, Annexin V-FITC (Biolegend) diluted in annexin V binding
buffer (BD Biosciences, San Jose, CA) was used following manufacturer’s protocol.
ELISA
Costar 3590 96-well ELISA plates were coated with 100μL PS at 20 μg/ml, uninfected erythro-
cyte lysate (109 erythrocytes/ml in PBS), T. b. brucei bloodstream forms or T. cruzi trypomasti-
gotes lysates (106 parasites/μl in PBS) diluted 1:500 in PBS, Calf thymus DNA (Sigma) diluted
1:100 in PBS or 200 proof Molecular Biology ethanol (PS) and allowed to evaporate at RT after
>16 h of incubation at 4˚C. Plates were washed 5 times with 200μL of PBS 0.05% tween 20 and
then blocked for 1 h with 200μL of PBS 3% BSA. After blocking, 100μL of plasma from mice
was diluted at 1:100 in blocking buffer and incubated for 2 h at 37˚C. Plates were washed again
5 times and incubated with 100μL of anti-mouse IgG-HRP (GE Healthcare) diluted at 1:2000
for 1 h at 37˚C. Plates were washed 5 more times and 100μL of TMB substrate (BD Biosci-
ences) was added until desired color was obtained. Reaction was stopped by with 50μL of Stop
buffer (Biolegend) and absorbance was read at 450 nm. The mean OD at 450 nm from tripli-
cate wells representing at least 3 independent infected mice was plotted in the graphs. For
human plasma ELISAs, a similar process was done, HAT patient plasma diluted 1:100 and
anti-human IgM-HRP (Millipore) or anti-human IgG-HRP (GE Healthcare) for detection.
The same dilution of a reference positive serum was used to calculate relative units (RU). Para-
site and cell lysates were prepared in RPMI 1640 medium by 10 freeze/thaw cycles.
ELISPOT assay
Mouse ELISPOTs were done as previously reported [12]. Mouse splenocyte suspensions from
uninfected control and T. b. brucei-infected mice (day 10 post infection) were obtained. White
blood cells were additionally purified in 45% Percoll at 25˚C for 20 min at 1500 × g to remove
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remaining erythrocytes. Specific B-cell populations were enriched through magnetic bead sort-
ing (Miltenyi) by positive selection with anti-CD11c (atypical) coated magnetic beads follow-
ing manufacturer’s protocol. Purification yield was assessed by flow cytometry prior to
addition to plate. 5 × 104 cells were added per well and incubated in RPMI 1640 supplemented
with 10% FBS in 96-well Costar 3590 ELISA plates (Corning Life Sciences, Tewksbury, MA)
precoated with 100μL of either capture anti-IgG (15 mg/ml), uninfected erythrocyte lysate (109
erythrocytes/ml in PBS), T. b. brucei or T. cruzi lysates (106 parasites/μl in PBS) diluted 1:500
in PBS, 25 μg/ml of Calf thymus DNA (Sigma) in PBS, PS at 20 μg/ml in 200 proof Molecular
Biology ethanol or PBS 10% BSA as control for 20 h at 37˚C with 5% CO2. Plates were washed
5 times with 200μL of PBS 0.05% tween 20 and then it was blocked with 200μL of PBS 10%
BSA for 1hr. Plates were washed 5 more times, 100μL of anti-mouse IgG biotinylated detection
antibody (Sigma, St. Louis, MO) was added at 1 μg/ml diluted in PBS 0.5% FBS for 2 h at RT.
100μL of Streptavidin-horseradish peroxidase (Mabtech AB, Nacka Strand, Sweden) was
added diluted in PBS 0.5% FBS for 1 h at RT. Plates were developed with 100μL of TMB sub-
strate (Mabtech AB, Nacka Strand, Sweden) for 15–20 min and then washed extensively with
water. Spots were quantified by microscopy.
In vitro activation assays
Naive B cells from Swiss Webster mice were purified as a CD43 negative fraction using anti-
CD43 beads (Miltenyi) and confirmed by flow cytometry to express CD19 (>96%) according
to manufacturer’s protocol. Cells were cultured in B-cell medium (RPMI 1640 10% Fetal
bovine serum (FBS), 100 U/mL Penicillin/Streptomycin, 2nM non-essential amino acids,
2mM L-Glutamine, 10mM Hepes and 50μl β-ME) at 5 × 106 cells per ml for 2 or 3 days as indi-
cated before analyzed by flow cytometry for T-bet expression. TLR7 agonist R848 (Mabtech)
was used at 1 μg/ml; anti-BCR (Fab0)2 anti-IgM (The Jackson Laboratory) was used at 5 μg/ml,
and IFN-γ (Peprotech) at 100 U/ml. Uninfected (3T3 mouse fibroblasts) and infected parasite
lysates (P. yoelii 17XNL strain from mice-infected blood [12], T. b. brucei or T. cruzi+/- fibro-
blasts from in-vitro cultures as described previously [20]) were added at a concentration of
1:10 (B-cell: infected cell), as measured before lysis. Parasite and cell lysates were prepared in
B-cell medium by 10 freeze/thaw cycles.
Patients
Human patient and local control plasma samples were collected in 2002–2003 in Uganda
according to protocols approved by the Grampian Research Ethics Committee (Aberdeen, UK)
and the Ministry of Health (Uganda). Patients were identified after either self-presentation in a
hospital setting or through community surveillance. Individuals (or their guardians) signed
consent forms after receiving standard information in their local language. The samples ana-
lyzed here were a subset of those previously described originally [13](Table 1). Follow up sam-
ples were taken on completion of chemotherapy and confirmation of negative parasitology 34–
60 days post recruitment. Importantly, individuals presenting with malarial co-infections were
excluded from the analysis. For patients, malaria co-infection was excluded on the basis of nega-
tive blood smear. Symptomatic exclusion is not possible due to symptom spectrum overlap with
HAT. For endemic controls, malaria co-infection exclusion was based by symptoms and blood
smear. Full detail of co-infection exclusion approach is in the original study [13,21].
Statistical analysis
All analyses were performed using GraphPad Prism version 5.0 (GraphPad Software, La Jolla,
CA). For mice experiments: Error bars represent the standard deviation from at least 3 mice
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assessed independently unless otherwise stated. We quantified P values using t-student, non-
parametric Spearman correlation or one-way ANOVA with Turkey’s multiple comparison test
as indicated. P< 0.05 was considered statistically significant.
Results
ABCs and autoantibodies expand during T. b. brucei, but not T. cruzi, acute
infection in mice
We first assessed whether ABCs expanded in mouse acute infection models of T. b. brucei and
T. cruzi. After gating out non-B cells (CD19−) in splenic lymphocytes (S1 Fig), we identified an
ABC population, as defined by high expression of CD11c and T-bet [17,18], which expanded
in T. b. brucei-infected mice (Fig 1). T. b. brucei-infected mice had significantly higher levels of
ABCs compared to uninfected mice, and similar levels compared to mice infected with the
mouse malaria parasite P. yoelii, which also induces the expansion of this population [12]. T.
cruzi–infected mice did not significantly induce expansion of ABCs.
Longitudinal analysis of autoantibodies and anemia during trypanosome
infection in mice
Next, we set out to characterize the levels of autoantibodies to three different autoantigens, PS,
DNA and a lysate of control uninfected red blood cells (RBC), in the plasma of T. b. brucei and
T. cruzi–infected mice during early acute-phase infections. We also assessed antibodies to a
lysate of T. b. brucei or T. cruzi for comparison. The levels of anti-parasite antibodies, as well as
all three autoantibodies in T. b. brucei–infected mice showed an increase for both the IgM and
IgG isotypes, although with different kinetics (Fig 2). Anti-PS IgM showed a sharp decline that
coincides with an increase of anti-PS IgG at day 12 post infection. In contrast, anti-RBC lysate
antibodies showed a steady increase throughout infection in both IgM and IgG, similarly to
anti-T. b. brucei antibodies. In T. cruzi-infected mice significant levels of anti-T. cruzi antibod-
ies were only detected at day 16 and autoantibodies at day 20 at the end of the acute phase of
the infection (Fig 3). Parasitemia of both infections show a similar profile, declining after day 8
of infection (Figs 2E and 3E).
Since autoimmune antibodies, and in particular anti-PS, contribute to anemia in malaria
[10], we further analyzed the relation between autoantibodies and erythrocyte levels. We
observed opposite tendencies, with a progressive decrease of erythrocyte levels and a continu-
ous increase in autoantibodies, where IgM appears earlier than IgG. No relationship was
Table 1. (related to Fig 6). Demographics for HAT patients and endemic community controls.
CC (n = 18) HAT (n = 39)
Age (years) 37.5(28, 50.5) 26 (15.5, 40.5)
Female sex (%) 9(50) 27 (67.5)








Follow up (n) — 19
Data presented as median (IQR) unless otherwise indicated. Sample collection as described in [13]
Abbreviations: community controls (CC), Human African Trypanosomiasis patients (HAT).
https://doi.org/10.1371/journal.pntd.0009814.t001
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found between any antibody and erythrocyte levels in T. cruzi-infected mice since they did not
suffer anemia (Fig 3).
ABCs are able to secrete autoantibodies during acute T. b. brucei infection
in mice
We next wanted to assess the capacity of ABCs to secrete autoantibodies during T. b. brucei
infection in mice by B-cell ELISPOT. Plates coated with our 3 autoantigens (PS, DNA or RBC
lysate) were incubated with splenocytes from infected (day 10) or control uninfected mice. We
observed the appearance of spots in wells incubated with splenocytes from infected mice, each
spot representing one antibody-secreting cell recognizing the coated antigen (Fig 4). To deter-
mine whether these spots were being produced specifically by ABCs, we enriched these cells
using CD11c positive selection by magnetic beads. We observed that CD11c+-enriched frac-
tions, representing ABCs, had significantly higher number of antibody-secreting cells (ASCs)
against PS compared to equal numbers of whole splenocytes from infected mice. All other
coated antigens had no significant differences in spot numbers between total splenocytes and
the CD11c+-enriched fraction.
Fig 1. ABCs expand during acute T. b. brucei infection in mice. (a) Representative plots of gated CD19+ splenocytes
to identify CD11c+ T-bet+ B cells from uninfected, day 8 post-infection with either P. yoelii, T. cruzi or T. b. brucei-
infected mice. (b) Quantification of CD11c+ T-bet+ B cells in (a). Bar graph represents the means ± SD of n = 3 mice
from at least two independent experiments. Significance assessed by one-way ANOVA with Turkey’s multiple
comparison test. �p< 0.05 ��p�0.01.
https://doi.org/10.1371/journal.pntd.0009814.g001
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T. b. brucei lysates along with IFN-γ induce differentiation of ABCs in vitro
To understand the mechanism by which ABCs expand during T. b. brucei infection, we studied
the effect that T. b. brucei antigens can have in directly promoting ABC differentiation. It is
well characterized that differentiation of ABCs from naïve B-cells is promoted by the cytokine
Fig 2. Antibodies and anemia during acute T. brucei infection in mice. Longitudinal analysis of erythrocyte count (blue line), IgM (black line) and IgG (grey
line) autoantibodies (a-c) or anti-T. brucei antibodies (d) in T. brucei-infected mice. (e) Bar graph with average parasitemia of mice infected with T. brucei. Line
and bar graphs represent the means ± SD of n = 3–6 mice per time point from two independent experiments. Significance between erythrocyte counts or levels
of antibodies at any day post-infection compared to day 0 was determined by one-way ANOVA. �p< 0.05, ��p< 0.01, ���p< 0.001, ����p< 0.0001.
https://doi.org/10.1371/journal.pntd.0009814.g002
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Fig 3. Antibodies and anemia during acute T. cruzi infection in mice. Longitudinal analysis of erythrocyte count
(blue line), IgM (black line) and IgG (grey line) autoantibodies (a-c) or anti-T. cruzi IgG antibodies (d) in T. cruzi-
infected mice. (e) Bar graph with average parasitemia of mice infected with T. cruzi. Line and bar graphs represent the
means ± SD of n = 3–6 mice per time point from two independent experiments. Significance between erythrocyte
counts or levels of antibodies at any day post-infection compared to day 4 was determined by one-way ANOVA. �p<
0.05, ��p< 0.01, ����p< 0.0001.
https://doi.org/10.1371/journal.pntd.0009814.g003
Fig 4. ABCs secrete autoantibodies during acute T. b. brucei infection in mice. B-cell ELISPOT of whole splenocytes or enriched CD11c+ B cells from
uninfected and T. b. brucei-infected mice at day 10 post infection against coated antigens: Phosphatidylserine (PS), uninfected red blood cell lysate (RBC),
Calf thymus DNA, Trypanosoma brucei parasite lysate and bovine serum albumin (BSA). Each data point represents the mean ± SD of n = 3 mice.
Experiments were repeated 2 times, one representative example is shown. Significance determined by one-way ANOVA. �p< 0.05, ��p< 0.01.
https://doi.org/10.1371/journal.pntd.0009814.g004
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IFN-γ, which induces the characteristic expression of T-bet in these cells [19]. Since IFN-γ is
found in high concentrations in the inflammatory environment induced by acute T. brucei
infection [22], it is likely that B-cells are exposed to this cytokine during infection.
To determine whether trypanosome molecules can induce the expression of T-bet on B
cells, we isolated naive B cells from control uninfected mice and incubated them in vitro with
lysates of T. b. brucei blood forms or a lysate of T. cruzi-infected fibroblasts or trypomastigotes,
alone or in combination with IFN-γ. As positive control, a lysate of P. yoelii infected erythro-
cytes and the TLR-7 agonist R848 [12] were used to stimulate cells. Uninfected fibroblasts
lysates were used as negative controls. B-cell receptor crosslinking (anti-IgM) was added to
bypass the need for antigen specificity. We observed that addition of each of the three signals
(IFN-γ, anti-IgM, and respective lysate) independently induces a very minor increase in T-bet
expression in B cells. Combinations of these signals two-by-two, and when the three were
added together, results in a synergistic increase in T-bet+ B cells (Fig 5). Particularly, the three
signals including T. b. brucei lysate had a strong T-bet induction comparable to the positive
control combinations. The combinations of three signals using T. cruzi-infected fibroblasts,
trypomastigotes or uninfected fibroblasts lysates did not augment T-bet induction more than
the two signals IFN-γ and anti-IgM. Taken together, these results indicate that T. b. brucei
molecules can contribute to the differentiation of T-bet expressing ABCs.
Blocking of PS during T. b. brucei infection in mice accelerates recovery
from anemia
To study the role of PS exposure in T. brucei-induced anemia, T. b. brucei-infected mice were
injected with annexin V, which specifically binds to PS exposed on cell membranes preventing
its interaction with other molecules [23,24]. We observed a significantly faster recovery from
anemia in annexin V-treated mice compared to vehicle-treated mice (Fig 6A). All annexin V-
treated mice survived at day 13 post-infection compared to 66.6% (4/6 mice) of the vehicle
group (Fig 6B). The parasitemia of both groups of mice was similar (Fig 6C), indicating that
Fig 5. IFNγ synergizes with trypanosome molecules to induce T-bet expression on B cells in-vitro. Purified naive B cells (CD43−)
from uninfected mice were cultured under the indicated conditions for 3 days, when T-bet expression was determined in CD19
+ cells. Agonist of TLR7 (R848). Experiments were repeated 2 times, one representative example is shown. Bars represent the means
± SD of n = 3 mice. Significance determined by one-way ANOVA. �p< 0.05, ��p< 0.01.
https://doi.org/10.1371/journal.pntd.0009814.g005
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the differences in erythrocyte levels and survival were not caused directly by the parasite.
These results suggest that blocking of PS by annexin V binding could inhibit erythrophagocy-
tosis and accelerate anemia recovery during infection.
Anti-PS antibodies are elevated in Human African Trypanosomiasis patients
To study whether anti-PS antibodies are present in Human African Trypanosomiasis (HAT)
patients, we analyzed the plasma of HAT patients from South East Uganda infected with T.
brucei rhodesiense along with uninfected local control donors (Table 1). We observed that
HAT patients present higher levels of IgM, but more significantly of IgG, anti-PS antibodies
compared to endemic controls (Fig 7A and 7B).
To determine whether these increases in anti-PS antibodies correlate with anemia in HAT
patients, we assessed the relationship between anti-PS antibodies and hematocrit, measured as
Fig 6. Annexin V ameliorates anemia during T. b. brucei infection in mice. (a-d) T. b. brucei-infected groups of
mice (n = 3 for each condition) were injected with annexin V (blue line) or vehicle alone (black line) at days 3 and 7
post infection. Number of erythrocytes per volume (a), survival (b) and average of parasitemia (c) of mice groups were
measured over time. Line graphs represent the means ± SD of n = 6 mice per time point from two independent
experiments. Significance determined by unpaired student T-test. �p< 0.05, ��p< 0.01.
https://doi.org/10.1371/journal.pntd.0009814.g006
Fig 7. Human African Trypanosomiasis induces a strong anti-PS antibody response that is inversely correlated with erythrocyte levels. Levels of
anti-PS IgM (a) or IgG (b) antibodies from HAT patients (n = 58 unique samples) or HAT-negative endemic controls (n = 18). Non-parametric
Spearman correlation analysis of anti-PS IgM (c) or IgG (d) with packed cell volume (PCV) of HAT patients at initial sample (n = 39) and HAT-
negative endemic controls (n = 18). Significance assessed by unpaired student T-test or Spearman correlation analysis. �p< 0.05, ����p< 0.0001.
https://doi.org/10.1371/journal.pntd.0009814.g007
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packed cell volume (PCV). We found a significant negative correlation of PCV levels in HAT
patients with anti-PS IgM, but more strongly with anti-PS IgG (Fig 7C and 7D). We found no
significant differences in the levels of anti-PS antibodies comparing samples taken during
acute disease with follow up samples from HAT patients, (S2 Fig). However, the levels of anti-
PS antibodies, both IgM and IgG, remain significantly different from healthy controls
(p = 0.0394 and 0.0001, respectively) in follow up samples, indicating that anti-PS remain ele-
vated after acute disease for at least one to two months. There was no correlation between
PCV and anti-PS antibodies in endemic non-HAT controls (S2D and S2E Fig). Taken
together, our results indicate that, similarly to mice, T. brucei rhodesiense human infection also
induces the generation of anti-PS autoantibodies that could contribute to anemia in humans.
Discussion
Anemia during infection with trypanosomes is a commonly reported complication in wide
range of hosts [25], but remains incompletely understood. Autoimmunity has been suggested
to play an important role in promoting pathology during trypanosome infection [3,26]. The
objective of this study was to assess whether autoimmunity against PS by atypical B-cells had a
role in acute anemia during infection with trypanosomes, hence expanding our previous stud-
ies of acute anemia during malaria [7–12]. During malaria, autoimmunity against PS is a tran-
sient phenomenon that contributes to acute-phase anemia through clearance of RBCs
mediated by the binding of anti-PS autoantibodies to exposed PS on RBC [10]. However, the
role that autoimmune antibodies play during acute-phase anemia in T. brucei infection has not
been thoroughly explored. To our knowledge this is the first study to assess the levels of ABCs,
autoantibodies, and their role in anemia development during acute T. brucei infection in mice.
ABCs were first discovered in aged mice and mouse models of autoimmunity, and have been
the hallmark of different human autoimmune diseases [17,18]. Our previous work has estab-
lished a key role for ABCs in promoting malarial anemia, through the secretion of anti-PS and
other autoantibodies, in both mice and patients [8,9,11,12]. These studies raised the question
whether ABCs could be playing a similar role during other highly inflammatory infections.
Increases in specific autoantibodies, particularly anti-PS IgG, are observed during early T.
b. brucei-infection in mice at the time of ABC expansion. The differentiation of ABCs during
autoimmunity has been described to depend on three different signals: B-cell receptor signal-
ing, Type 1 inflammatory cytokines such as IFN-γ and IL21 and a nucleic acid receptor such as
TLR7 or 9 [17,18]. During malarial infection, parasite DNA sensing through TLR9 along with
IFN-γ had a prominent role in ABC expansion [12]. We found here that T. b. brucei molecules,
coming from a whole parasite lysate, can also synergize with IFN-γ to promote ABC differenti-
ation in-vitro as measured by T-bet induction, suggesting that T. b. brucei RNA or DNA may
contribute to this process.
Comparing T. b. brucei and T. cruzi acute infections in mice, we observed similar parasite-
mia kinetics, however the anti-PS response was quite different since T. cruzi infection induced
no detectable anti-PS until day 20, while T. brucei infected mice show significant titers at day 8
for IgM and day 12 for IgG. Our results also show that acute T. b. brucei, but not T. cruzi, infec-
tion in mice led to robust expansion of ABCs that are able to secrete autoantibodies, particu-
larly anti-PS IgG, during infection in mice. Since T. b. brucei, but not T. cruzi, lysates were able
to induce the expansion of ABCs in vitro it is likely that the difference in ABC activation and
autoimmune antibody levels during the two infections may be mediated by the intrinsic capac-
ity of T. b. brucei molecules to trigger this response.
Anemia during any infection, including during T. brucei infection, is a multi-factorial
pathology that involves the disruption of multiple physiological and immunological processes
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including erythropoiesis, erythrophagocytosis, cell lysis, iron metabolism, oxidative stress and
inflammation [24,27–31]. We found that acute T. cruzi infection did not cause anemia, and
did also not induce significant ABC or autoantibody levels in mice during the early acute
phase of infection. These differences with T. brucei infection could be due to the divergent
host immune response to these two parasitic infections, which in T. brucei-infected mice
includes very high levels of inflammatory cytokines [32], extracellular vesicles [31], activation
of the mononuclear phagocyte system [33], among others. Importantly, trypanosome parasites
are well known to establishing chronic infections [34], hence inducing prolonged or delayed
anemia [25]. The factors that contribute to chronic anemia [35] probably differ, such as iron
availability [36], from the ones that are transiently present during acute-phase anemia, such as
autoimmunity [11]. It remains to be determined whether anti-PS antibodies and other autoan-
tibodies could have a role in chronic anemia by trypanosomes.
During malaria, anti-PS IgG antibodies promote anemia by binding to PS on uninfected
erythrocytes and enhancing their premature clearance. T. b. brucei infection also leads to
enhanced exposure levels of PS on erythrocytes [37] and elevated levels of anti-PS, suggesting
that this mechanism could contribute to anemia.
Different studies have attributed induction of anemia during T. brucei infection to various
mechanisms including hemodilution [37], impaired erythropoiesis or release of RBCs into the
circulation [38] and accelerated erythrophagocytosis [39]. Indeed, activation of the mononu-
clear phagocyte system [33] has been attributed an essential role in mediating anemia during
T. brucei infection. On the other hand, B-cells have been attributed a non-essential role in ane-
mia induction since anemia progresses similarly in B-cell deficient mice during T. brucei infec-
tion [40]. Rather than anti-PS antibodies having a role in inducing anemia, we hypothesize
that they exert their effect by delaying the recovery of RBC levels. Anti-PS binding to PS, that
is largely exposed on young reticulocytes [10,41], would promote their premature clearance by
phagocytes, prolonguing anemia. Accordingly, our results showed that masking PS with
Annexin V accelerates RBC recovery. This enhancement in RBC recovery by Annexin V could
be mediated by masking PS from phagocytes that recognize it through PS receptors or through
Fc receptors recognizing anti-PS antibodies. However, our studies did not measure directly
the role of anti-PS antibodies in mice and further studies that would support this hypothesis
should address this point. Such experiments could include injection of purified anti-PS IgG
antibodies to T. brucei-infected mice in combination or not with Annexin V and assess its
effect on circulating RBC/ reticulocyte levels as well as on RBC progeny in the spleen and bone
marrow. Additionally, the use of RBCs labeled with biotin or radioactive isotopes has been his-
torically used to assess RBC recovery and survival [42]. An alternative approach could be to
inject labeled RBCs into T. brucei-infected mice with a follow up challenge injection of purified
anti-PS antibodies in combination +/- Annexin V and measure RBC turnover and recovery
from anemia. Altogether, our data adds PS exposure and, possibly its targeting by anti-PS anti-
bodies, as an important factor delaying RBC recovery and prolonging anemia.
Several T. brucei proteins, such as variant surface glycoprotein [43] and trypanosome lytic
factor 2 [44] contain antigens that are recognized by autoimmune antibodies in mice and
humans never exposed to this pathogen. Trypanosoma brucei infections lead to B-cell poly-
clonal activation [24,45] that could be a main driver causing secretion of autoantibodies. Apart
from autoantibodies, other unrelated antibodies such as antibodies against irrelevant VSGs
[46], have also been reported during T. brucei infection. It has been hypothesized that these
irrelevant antibodies serve as way to dilute out the pathogen specific antibody responses, serv-
ing as an immune evasion mechanism and prolonging infection [47]. Our results suggest an
additional interpretation where autoantibodies from this polyclonal response could also be
considered damaging for the host by delaying the recovery from anemia.
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The relevance of anti-PS IgG antibodies in promoting anemia has been studied in various
cohorts of human malaria caused by different Plasmodium species [7–10,48]. Here we also
report the presence of high levels of anti-PS IgM and IgG antibodies in HAT patients that cor-
related negatively with PCV levels, suggesting a relation between autoimmunity to PS and ane-
mia during human acute infection.
Altogether these data suggest that autoimmune B-cells could have a role in anemia, particu-
larly in delaying RBC recovery, through the secretion of autoantibodies during T. brucei acute
infection.
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cei Strains Tagged with Blue and Red-Shifted Luciferases for Bioluminescent Imaging in Murine Infec-
tion Models. PLoS Negl Trop Dis. 2014; 8. https://doi.org/10.1371/journal.pntd.0003054 PMID:
25144573
15. Claes F, Vodnala SK, Van Reet N, Boucher N, Lunden-Miguel H, Baltz T, et al. Bioluminescent imaging
of Trypanosoma brucei shows preferential testis dissemination which may hamper drug efficacy in
sleeping sickness. PLoS Negl Trop Dis. 2009; 3. https://doi.org/10.1371/journal.pntd.0000486 PMID:
19621071
16. Andriani G, Chessler ADC, Courtemanche G, Burleigh BA, Rodriguez A. Activity in vivo of anti-trypano-
soma cruzi compounds selected from a high throughput screening. PLoS Negl Trop Dis. 2011; 5.
https://doi.org/10.1371/journal.pntd.0001298 PMID: 21912715
17. Phalke S, Marrack P. Age (autoimmunity) associated B cells (ABCs) and their relatives. Current Opinion
in Immunology. 2018. pp. 75–80. https://doi.org/10.1016/j.coi.2018.09.007 PMID: 30388513
PLOS NEGLECTED TROPICAL DISEASES T. brucei-induced anemia is associated with autoimmunity
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0009814 September 29, 2021 16 / 18
18. Cancro MP. Age-Associated B Cells. Annu Rev Immunol. 2020; 38: 315–340. https://doi.org/10.1146/
annurev-immunol-092419-031130 PMID: 31986068
19. Rubtsova K, Rubtsov A V., Cancro MP, Marrack P. Age-Associated B Cells: A T-bet–Dependent Effec-
tor with Roles in Protective and Pathogenic Immunity. J Immunol. 2015; 195: 1933–1937. https://doi.
org/10.4049/jimmunol.1501209 PMID: 26297793
20. Varghese S, Rahmani R, Russell S, Deora GS, Ferrins L, Toynton A, et al. Discovery of Potent N-Ethy-
lurea Pyrazole Derivatives as Dual Inhibitors of Trypanosoma brucei and Trypanosoma cruzi. ACS Med
Chem Lett. 2019. https://doi.org/10.1021/acsmedchemlett.9b00218 PMID: 32184957
21. MacLean LM, Odiit M, Chisi JE, Kennedy PGE, Sternberg JM. Focus-specific clinical profiles in human
African trypanosomiasis caused by trypanosoma brucei rhodesiense. PLoS Negl Trop Dis. 2010; 4: 1–
12. https://doi.org/10.1371/journal.pntd.0000906 PMID: 21151878
22. Bakhiet A-MO. Immunopathogenesis of experimental African trypanosomiasis: Interactions between
Trypanosoma brucei brucei, CD8(+) T cells and interferon gamma. ProQuest Dissertations and Theses.
1993. Available: https://search.proquest.com/docview/304078734?accountid=29068
23. Callahan MK, Williamson P, Schlegel RA. Surface expression of phosphatidylserine on macrophages is
required for phagocytosis of apoptotic thymocytes. Cell Death Differ. 2000; 7: 645–653. https://doi.org/
10.1038/sj.cdd.4400690 PMID: 10889509
24. Vijay R, Guthmiller JJ, Sturtz AJ, Crooks S, Johnson JT, Li L, et al. Hemolysis-associated phosphatidyl-
serine exposure promotes polyclonal plasmablast differentiation. J Exp Med. 2021; 218. https://doi.org/
10.1084/jem.20202359 PMID: 33830176
25. Mbaya A, Kumshe H, Okwudiri C. The Mechanisms of Anaemia in Trypanosomosis: A Review. Anemia.
2012. https://doi.org/10.5772/29530
26. MacKenzie AR, Boreham PFL. Autoimmunity in trypanosome infections. I. Tissue autoantibodies in Try-
panosoma (Trypanozoon) brucei infections of the rabbit. Immunology. 1974; 26: 1225–12238. PMID:
4211823
27. Wolkmer P, da Silva AS, Traesel CK, Paim FC, Cargnelutti JF, Pagnoncelli M, et al. Lipid peroxidation
associated with anemia in rats experimentally infected with Trypanosoma evansi. Vet Parasitol. 2009;
165: 41–46. https://doi.org/10.1016/j.vetpar.2009.06.032 PMID: 19628334
28. Frenkel D, Zhang F, Guirnalda P, Haynes C, Bockstal V, Radwanska M, et al. Trypanosoma brucei Co-
opts NK Cells to Kill Splenic B2 B Cells. PLoS Pathog. 2016; 12. https://doi.org/10.1371/journal.ppat.
1005733 PMID: 27403737
29. Mabbott N, Sternberg J. Bone marrow nitric oxide production and development of anemia in Trypano-
soma brucei-infected mice. Infect Immun. 1995; 63: 1563–1566. https://doi.org/10.1128/iai.63.4.1563-
1566.1995 PMID: 7890423
30. Amole BO, Clarkson AB, Shear HL. Pathogenesis of anemia in Trypanosoma brucei-infected mice.
Infect Immun. 1982; 36: 1060–1068. https://doi.org/10.1128/iai.36.3.1060-1068.1982 PMID: 7201455
31. Szempruch AJ, Sykes SE, Kieft R, Dennison L, Becker AC, Gartrell A, et al. Extracellular Vesicles from
Trypanosoma brucei Mediate Virulence Factor Transfer and Cause Host Anemia. Cell. 2016; 164: 246–
257. https://doi.org/10.1016/j.cell.2015.11.051 PMID: 26771494
32. Musaya J, Matovu E, Nyirenda M, Chisi J. Role of cytokines in Trypanosoma brucei-induced anaemia:
A review of the literature. Malawi Med J. 2015; 27: 45–50. https://doi.org/10.4314/mmj.v27i2.3 PMID:
26405511
33. Stijlemans B, De Baetselier P, Magez S, Van Ginderachter JA, De Trez C. African trypanosomiasis-
associated anemia: The contribution of the interplay between parasites and the mononuclear phagocyte
system. Frontiers in Immunology. 2018. https://doi.org/10.3389/fimmu.2018.00218 PMID: 29497418
34. Pays E, Vanhamme L, Pérez-Morga D. Antigenic variation in Trypanosoma brucei: Facts, challenges
and mysteries. Current Opinion in Microbiology. 2004. pp. 369–374. https://doi.org/10.1016/j.mib.2004.
05.001 PMID: 15288623
35. Ganz T. Anemia of chronic disease. Molecular Hematology. 2019. pp. 155–160. https://doi.org/10.
1002/9781119252863.ch12
36. Nairz M, Weiss G. Iron in infection and immunity. Molecular Aspects of Medicine. 2020. https://doi.org/
10.1016/j.mam.2020.100864 PMID: 32461004
37. Stijlemans B, Brys L, Korf H, Bieniasz-Krzywiec P, Sparkes A, Vansintjan L, et al. MIF-Mediated Hemo-
dilution Promotes Pathogenic Anemia in Experimental African Trypanosomosis. PLoS Pathog. 2016;
12. https://doi.org/10.1371/journal.ppat.1005862 PMID: 27632207
38. Nishimura K, Nakaya H, Nakagawa H, Matsuo S, Ohnishi Y, Yamasaki S. Effect of trypanosoma brucei
brucei on erythropoiesis in infected rats. J Parasitol. 2011; 97: 88–93. https://doi.org/10.1645/GE-2522.
1 PMID: 21348612
PLOS NEGLECTED TROPICAL DISEASES T. brucei-induced anemia is associated with autoimmunity
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0009814 September 29, 2021 17 / 18
39. Cnops J, De Trez C, Stijlemans B, Keirsse J, Kauffmann F, Barkhuizen M, et al. NK-, NKT- and CD8-
Derived IFNγDrives Myeloid Cell Activation and Erythrophagocytosis, Resulting in Trypanosomosis-
Associated Acute Anemia. PLoS Pathog. 2015; 11. https://doi.org/10.1371/journal.ppat.1004964
PMID: 26070118
40. Magez S, Schwegmann A, Atkinson R, Claes F, Drennan M, De Baetselier P, et al. The role of B-cells
and IgM antibodies in parasitemia, anemia, and VSG switching in Trypanosoma brucei-infected mice.
PLoS Pathog. 2008; 4. https://doi.org/10.1371/journal.ppat.1000122 PMID: 18688274
41. Mankelow TJ, Griffiths RE, Trompeter S, Flatt JF, Cogan NM, Massey EJ, et al. Autophagic vesicles on
mature human reticulocytes explain phosphatidylserine-positive red cells in sickle cell disease. Blood.
2015; 126: 1831–1834. https://doi.org/10.1182/blood-2015-04-637702 PMID: 26276668
42. Roussel C, Buffet PA, Amireault P. Measuring post-transfusion recovery and survival of red blood cells:
Strengths and weaknesses of Chromium-51 labeling and alternative methods. Front Med. 2018; 5.
https://doi.org/10.3389/fmed.2018.00130 PMID: 29868587
43. Müller N, Mansfield JM, Seebeck T. Trypanosome variant surface glycoproteins are recognized by self-
reactive antibodies in uninfected hosts. Infect Immun. 1996; 64: 4593–4597. https://doi.org/10.1128/iai.
64.11.4593-4597.1996 PMID: 8890212
44. Verdi J, Zipkin R, Hillman E, Gertsch RA, Pangburn SJ, Thomson R, et al. Inducible Germline IgMs
Bridge Trypanosome Lytic Factor Assembly and Parasite Recognition. Cell Host Microbe. 2020; 28:
79–88.e4. https://doi.org/10.1016/j.chom.2020.04.012 PMID: 32416060
45. Diffley P. Trypanosomal surface coat variant antigen causes polyclonal lymphocyte activation. J Immu-
nol. 1983; 131: 1983–1986. PMID: 6604754
46. Pinger J, Chowdhury S, Papavasiliou FN. Variant surface glycoprotein density defines an immune eva-
sion threshold for African trypanosomes undergoing antigenic variation. Nat Commun. 2017; 8. https://
doi.org/10.1038/s41467-017-00959-w PMID: 29018220
47. Stijlemans B, Caljon G, Van Den Abbeele J, Van Ginderachter JA, Magez S, De Trez C. Immune eva-
sion strategies of Trypanosoma brucei within the mammalian host: Progression to pathogenicity. Fron-
tiers in Immunology. 2016. https://doi.org/10.3389/fimmu.2016.00233 PMID: 27446070
48. Barber BE, Grigg MJ, Piera K, Amante FH, William T, Boyle MJ, et al. Antiphosphatidylserine Immuno-
globulin M and Immunoglobulin G Antibodies Are Higher in Vivax Than Falciparum Malaria, and Associ-
ated With Early Anemia in Both Species. J Infect Dis. 2019; 220: 1435–1443. https://doi.org/10.1093/
infdis/jiz334 PMID: 31250022
PLOS NEGLECTED TROPICAL DISEASES T. brucei-induced anemia is associated with autoimmunity
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0009814 September 29, 2021 18 / 18
